Prenatal Intravenous Iron and Child Growth: A secondary analysis of a Randomized Clinical Trial

<p dir="ltr">The dataset includes de-identified data of 738 pregnant women and their infants from Southern Malawi, who were randomised in the REVAMP (Randomised trial of intraVenous iron for Anaemia in Malawian Pregnant women) trial and consented to REVAMP EXTENDED. This trial, aimed to examine the impact of a single antenatal dose of a modern IV iron formulation (ferric carboxymaltose) compared to standard care (oral iron) on growth outcomes in infants from birth to 12 months postpartum.</p><p dir="ltr">This project comprises three separate datasets and corresponding data dictionaries that underpin the variables used in the analysis presented in the main manuscript. These include:</p><p dir="ltr">- maternal characteristics,</p><p dir="ltr">- infant characteristics at delivery,</p><p dir="ltr">- efficacy/growth scores.</p><p dir="ltr">To protect the privacy and confidentiality of the research participants, access is limited to de-identified data only. Certain variables have been excluded due to their potential for re-identification, as outlined in the data dictionaries. These variables are available from the corresponding author (Sant-Rayn Pasricha: pasricha.s@wehi.edu.au) upon reasonable request.</p><p dir="ltr">Participant record identifiers for both mothers and infants were generated independently to minimise re-identification risk and therefore cannot be used to link maternal and infant data.</p><p><br></p>